Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @cmrherder
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @cmrherder
-
Prikvačeni tweet
Published today in the Milbank Quarterly : My qualitative inquiry into the sate of lifecycle regulation
@US_FDAhttps://onlinelibrary.wiley.com/doi/full/10.1111/1468-0009.12413 …Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Matthew Herder proslijedio/la je Tweet
"Remember: the Canada Pension Plan and medicare itself were both introduced in the 1960s by a minority government," say Roy Romanow and Greg Marchildon in their argument for
#pharmacare now.https://www.thestar.com/opinion/contributors/2020/02/03/pharmacare-now-completing-medicares-vision-for-the-benefit-of-all-canadians.html …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Matthew Herder proslijedio/la je Tweet
Quick retraction of faulty coronavirus paper posted to
@biorxivpreprint shows value of swift scientific communication to correct/improve faulty science - the process worked - and shows opportunity that can come from earlier learning about each other's workhttps://www.statnews.com/2020/02/03/retraction-faulty-coronavirus-paper-good-moment-for-science/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Matthew Herder proslijedio/la je Tweet
Grant deadline extended. Up to USD $150,000 available for reanalyzing clinical trials - for researchers interested in using unpublished data to publish clinical trials that are either unpublished or were incompletely reported.https://restoringtrials.org/2020/02/03/grants/ …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Also lovely to see
@hughalderwick, a ‘fellow’ Harkness fellow, appear in the list too!Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Wow, really honoured to see that my paper on lifecycle regulation
@US_FDA is being read. Huge thanks to@commonwealthfnd for funding the research, colleagues like@akapczynski@jsross119@Yale_CRIT for critical feedback, and to@MilbankFund for a great publishing experiencehttps://twitter.com/tarastrome/status/1223307183716290563 …Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Matthew Herder proslijedio/la je Tweet
Top universities thrash out a joint position on data sharing as
#coronavirus spread shows need for accelerating research#openscience https://www.leru.org/files/Sorbonne-declaration.pdf …pic.twitter.com/myen2dtTYR
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Matthew Herder proslijedio/la je Tweet
Interested in government funding and pricing of resulting products? New piece out by
@AmeetSarpatwari@akesselheim@ali_lapidus discussing CRADAs and NIH’s reasonable pricing clause@PORTAL_Research https://twitter.com/ameetsarpatwari/status/1222185608849682433 …Tweet je nedostupan.Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Matthew Herder proslijedio/la je Tweet
Strong leadership from
@bmj_latest@fgodlee@KamranAbbasi, launching a divestment campaign "Health professionals and medical organisations should not accept the world as it is ... Taking action is a duty to the people we serve and to future generations."https://www.bmj.com/content/368/bmj.m167 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Matthew Herder proslijedio/la je Tweet
When people talk about missions, I always warn them: if this is something that makes you feel comfortable and happy and cosy, then you haven't understood it, because it's actually about fundamentally changing how we think about innovation.https://www.wired.co.uk/article/mariana-mazzucato …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Mandatory disclosure + meaningful support for PAOs w/out corporate $ to participate in policy/decision-making processes. Disclosure alone is not enough.https://twitter.com/ColleenFuller/status/1220404543202004992 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Matthew Herder proslijedio/la je Tweet
A 15% response rate in 62 patients (no control arm) leads to drug approval This is dangerous stuff. If the FDA decides not to enforce an efficacy requirement for new drugs, then patients pay the price with massive uncertainty.https://www.businesswire.com/news/home/20200123005858/en/Epizyme-Announces-U.S.-FDA-Accelerated-Approval-TAZVERIK%E2%84%A2 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Matthew Herder proslijedio/la je Tweet
Our latest in
@JAMAPediatrics: Drug company marketing of stimulants is widespread, affected as many as 1 in 18 docs (and 1 in 5 pediatricians) nationwide between 2014-2018. All this amid rising prescribing and potential misuse.@The_BMChttps://jamanetwork.com/journals/jamapediatrics/fullarticle/2759018 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Matthew Herder proslijedio/la je Tweet
The more I read about the approval of Sarepta's golodirsen (Vyondys 53), the more it boggles the mind. FDA's CRL with big concerns about efficacy, safety, and the lack of precedent eteplirsen confirmatory trial (over which the drug was approved anyway): https://www.accessdata.fda.gov/drugsatfda_docs/nda/2019/211970Orig1s000OtherActionLtrs.pdf …
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Matthew Herder proslijedio/la je Tweet
FDA's Unger overruled again on
$SRPT, this time by OND's Stein (last time it was Woodcock)https://www.raps.org/news-and-articles/news-articles/2020/1/initial-golodirsen-crl-raises-alarms-over-eteplirs …Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Matthew Herder proslijedio/la je Tweet
--- VICTORY FOR MEDICAL TRANSPARENCY --- European court upholds access to Clinical Study Reports -> excellent news for patients worldwide <- https://www.transparimed.org/single-post/2020/01/22/Court-of-Justice-Clinical-Study-Reports …
#AllTrials#clinicaltrials#transparencypic.twitter.com/qka2myaESa
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Matthew Herder proslijedio/la je Tweet
$SRPT Based on the last line it certainly looks like the lack of progress in starting a confirmatory trial for etep was a significant concern for the golo NDA as previously reportedhttps://twitter.com/jq1234t/status/1219843707744280576 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Matthew Herder proslijedio/la je Tweet
Merck and PTC Therapeutics lose in their lawsuit against the European Medicines Agency transparency policy: "The Court confirms the right of access to documents contained in the file of a marketing authorisation application for a medicinal product" https://curia.europa.eu/jcms/upload/docs/application/pdf/2020-01/cp200006en.pdf …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
ICYMI - "The Merck [sic] Ebola Vaccine"* published last week co-authored with
@JEGanthro +@IP_policy https://academic.oup.com/jlb/advance-article/doi/10.1093/jlb/lsz019/5706941?searchresult=1 … *That's the title I always wanted to give it And if you're interested in a deeper dive, here's the talk from March 2019:https://www.youtube.com/watch?v=rmeALiEx2e8&feature=youtu.be …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Matthew Herder proslijedio/la je Tweet
Great thread, and a great paper led by
@cmorten2 describing the status of "failure to warn" suits after 2019#SCOTUS decision in Merck v. Albrecht - all you#drugsafety folks on#healthpolicytwitter should give it a readhttps://twitter.com/cmorten2/status/1219609008455266304 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Matthew Herder proslijedio/la je Tweet
In "Pharmaceutical Ethics and Grassroots Activism in the United States: A Social History Perspective", just out in the Journal of Bioethical Inquiry, we look at public health activism in the Progressive Era, the postwar era and the present day. https://doi.org/10.1007/s11673-019-09956-8https://doi.org/10.1007/s11673-019-09956-8 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.